MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SHJBF
  4. News
SHJBF
Quote
Short
News
Articles
Message Board

Shanghai Junshi (OTCMKTS : SHJBF ) News

Shanghai Junshi (OTCMKTS: SHJBF) News Releases

SHJBF News Releases
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
SHJBF : OTC
GlobeNewswire
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces Primary Endpoints Met in JS001sc's Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces FDA's Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates
SHJBF : OTC
GlobeNewswire
Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.